

| Catalog No. | DB941018 |
|---|---|
| Description |
Bevacizumab ELISA Kit (DB941018) — Quantitative sandwich ELISA for Bevacizumab. Sample: Plasma, Serum. Range: 312.5 - 20, 000 ng/mL. Sensitivity: 98.1 ng/mL.
Highlights
|
| Sample type | Plasma, Serum |
| Sensitivity | 98.1 ng/mL |
| Range | 312.5 - 20, 000 ng/mL |
| Accession | P15692 |
| Applications | ELISA |
| Detection method | Colorimetric |
| Assay type | Quantitative |
| Recovery | 80-120% |
| Shipping | 2-8 ℃ |
| Stability and Storage | When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. For unopened kits, if you want to prolong the storage time, please store the Standard, Detection A, Detection B and Microplate at - 20℃, the rest reagents should be store at 4℃. |
| Specifications | Bevacizumab |
| Alternate Names | 12-IgG1, F(ab)-12 IgG1, Fab-12 IgG1, rhuMAb-VEGF, ABP 215, 216974-75-3 |
| Background | Vascular endothelial growth factor A, long form (Bevacizumab) is a ~43 kDa protein. Participates in the induction of key genes involved in the response to hypoxia and in the induction of angiogenesis such as HIF1A. Involved in protecting cells from hypoxia-mediated cell death. 1. Katsman, M. et al. (2022) Cells 11. PMID: 35455969 |
| Note | For Research Use Only. |
Contact us for custom quotes, bulk requests and any other issues.
Mail: support@abinScience.com
+86-27-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский